ArticleVaccine2010

Population-based analysis of Actinobacillus pleuropneumoniae ApxIVA for use as a DIVA antigen.

Ciaragh O'Neilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.